PPARγ agonists induce apoptosis by inductionof PTEN expression in pancreatic, breast, and colon cancer cells [33] and inhibition of NFκB and Bcl-2 expression in colon cancercells [34]. The gene discussed is PPARG; the disease is malignant colon neoplasm.